Why the study?
Does adipose tissue renin-angiotensin system activity modulate systemic markers of insulin sensitivity and intrarenal RAS in mouse models?
Does adipose tissue renin-angiotensin system activity modulate systemic markers of insulin sensitivity and intrarenal RAS in mouse models?
Alterations in adipose tissue renin-angiotensin system activity significantly impact local and systemic physiology, potentially contributing to the detrimental health effects of obesity.
Adipose RAS modulation affects metabolic and renal markers in mice; hypothesis-generating for human obesity-related disease, no practice change yet.
BACKGROUND: The adipose tissue renin-angiotensin system (RAS) contributes to regulation of fat mass and may also impact systemic functions such as blood pressure and metabolism. METHODS AND RESULTS: A panel of mouse models including mice lacking angiotensinogen, Agt (Agt-KO), mice expressing Agt solely in adipose tissue (aP2-Agt/Agt-KO), and mice overexpressing Agt in adipose tissue (aP2-Agt) was studied. Total body weight, epididymal fat pad weight, and circulating levels of leptin, insulin, and resistin were significantly decreased in Agt-KO mice, while plasma adiponectin levels were increased. aP2-Agt mice exhibited increased adiposity and plasma leptin and insulin levels compared to wild type (WT) controls. Angiotensinogen and type I Ang II receptor protein levels were also elevated in kidney of aP2-Agt mice. CONCLUSION: These findings demonstrate that alterations in adipose RAS activity significantly impact both local and systemic physiology in a way that may contribute to the detrimental health effects of obesity.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: